Plasma catecholamine metabolites in Schizophrenics: Evidence for the two-subtype concept
Authors:
- Teny-Yi ChenTCTeny-Yi Chen
- Shi-Kwang LinSLShi-Kwang Lin
- For-Wei LungFLFor-Wei Lung
- Wen-Long LinWLWen-Long Lin
- Wei-Herng HuWHWei-Herng Hu
- Eng-Kung YehEYEng-Kung Yeh
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 27 (5) , 510-518
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dopamine as a mediator of a central stabilizing system *1Comments on ?the current status of the dopamine hypothesis of schizophrenia?Neuropsychopharmacology, 1988
- Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patientsNeuropsychopharmacology, 1987
- Plasma Homovanillic Acid Concentration and the Severity of Schizophrenic IllnessScience, 1985
- Impaired noradrenergic transmission in schizophrenia?Life Sciences, 1984
- Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or ChlorpromazineActa Psychiatrica Scandinavica, 1984
- Rapid and Simple Determination of Homovanillic Acid in Plasma Using High Performance Liquid Chromatography with Electrochemical DetectionActa Pharmacologica et Toxicologica, 1983
- Plasma homovanillic acid as an index of brain dopamine metabolism: Enhancement with debrisoquinLife Sciences, 1983
- Brain catecholamines in schizophrenia — a good case for noradrenalineNature, 1982
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- THE BRIEF PSYCHIATRIC RATING SCALEPsychological Reports, 1962